ISCT Asia 2026 Singapore Regional Meeting is the inaugural regional meeting of the International Society for Cell & Gene Therapy (ISCT) in Asia. The four-day in-person conference brings together academia, clinicians, industry, and regulators across the development, manufacture, and delivery of cell and gene therapies in Asia. Designed to bridge international standards with the unique translational landscape of the APAC region, the meeting provides a high-impact platform to share groundbreaking advancements and drive the future of cell and gene therapy in the region. The program features 140+ presentations across cell and gene therapy translation, including oral abstract sessions, an Elevator Pitch Competition, and Poster Networking Receptions. Corporate sessions and company presentations will explore emerging technologies and innovations shaping the CGT industry. Three specialized training events are also offered: a two-day hands-on GMP Laboratory Bootcamp in Cell Therapy Biomanufacturing (August 31 – September 1), an expert-led Clinical CGT Immune Monitoring and Immunobiology Workshop (September 1), and a Cell Therapy Manufacturing course (September 5). Dr. Bruce Levine (University of Pennsylvania), co-inventor of the first FDA-approved CAR T-cell therapy (Kymriah), will deliver the opening keynote.

Dates: 2 – 5 September 2026

Time:

2 September 08:00 – 20:00

3 September 08:00 – 19:30

4 September 08:00 – 16:00

5 September 08:00 – 18:30

Venue: Suntec Singapore Convention & Exhibition Centre, L3

Official Event Website: https://www.isctglobal.org/isctasia2026singapore/home-2026